$50MGrowth, 7 April 2026
Growth financing led by Novo Holdings to support stroke reperfusion technologies.
- Amount
- $50M
- Stage
- Growth
- Announced
- 7 April 2026
- Lead
- Novo Holdings
- Use of funds
- Growth financing led by Novo Holdings to support stroke reperfusion technologies.
- Checked
- Announced by the company
- Source
- Route 92 Medical announces $50M growth financing led by Novo Holdings globenewswire.com